Nath Bio-Genes (India) DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.84×	0.90×	0.95×	0.95×	0.97×
	0.96×	0.96×	0.88×	0.89×	0.79×
	9.3%	10.9%	12.6%	14.0%	15.2%
	0.42×	0.42×	0.38×	0.40×	0.39×
	1.61×	1.61×	1.59×	1.44×	1.38×
	5.1%	6.3%	6.4%	6.9%	6.3%
	6.3%	6.3%	6.2%	6.7%	6.3%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NATHBIOGEN₹131.40

Nath Bio-Genes (India) Limited

· FMCG & Retail

₹ CrorePeersSARVESHWAR INDOUS SUKHJITS KOHINOOR AGRITECH REGAAL BSHSL GULPOLYMcap ₹250 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.97	0.95	0.95	0.90	0.84
Interest Burden (Pretax/EBIT) ×	0.79	0.89	0.88	0.96	0.96
EBIT Margin %	15.17	14.01	12.60	10.89	9.25
Asset Turnover ×	0.39	0.40	0.38	0.42	0.42
Financial Leverage (Assets/Equity) ×	1.38	1.44	1.59	1.61	1.61
ROE (5-step product, year-end total equity) %	6.27	6.88	6.40	6.34	5.06
ROE (owners' profit / average owners' equity) %	6.28	6.70	6.15	6.28	6.28

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.